de Angelis Lorenzo, Barca Francesco, Rizzo Stanislao, Di Leo Laura, Oliverio Leandro, Caporossi Tomaso
Department of Translational Surgery and Medicine, Ophthalmology, Department of NEUROFARBA, University of Florence, Careggi, Florence, Italy.
UOC Oculistica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Eur J Ophthalmol. 2022 May;32(3):NP67-NP70. doi: 10.1177/1120672121990634. Epub 2021 Feb 10.
To report the surgical outcomes of penetrating keratoplasty (PKP) and sutureless scleral fixation (SSF) using Carlevale Lens (Soleko) combined procedure to solve corneal failure and aphakia in vitrectomized eyes and discuss eventual advantages of this new approach.
Two patients underwent primary wound repair and pars plana vitrectomy after a penetrating ocular trauma and were referred to the author's clinic. The PKP and SSF-Carlevale lens implantation were performed under retrobulbar anesthesia. Intraoperative and postoperative complications were recorded, intraocular lens positioning was evaluated using anterior segment optical coherence tomography (AS-OCT) and endothelial cell density was determined using an endothelial microscope. Both patients completed 12 months follow-up.
The surgery was performed without intraoperative complications. After 1 month, the lens was fixed well, and the graft showed no sign of rejection. At the last visit after 12 months, the corneal graft remained transparent with good endothelial cell density in both cases; conjunctival scarring or inflammation and plugs externalization did not occur during follow-ups. Best-corrected visual acuity was 4/10 Snellen in the first case, while in the second case, we witnessed a limited visual recovery of 1/20 Snellen due to retinal issues.
We report the feasibility of secondary IOL implantation using Carlevale with penetrating keratoplasty. The relative of ease of Carlevale lens implantation through the transscleral plugs reduces the open globe length resulting in a safer procedure, especially for vitrectomized eyes.
报告采用卡尔维勒晶状体(索莱科)联合手术进行穿透性角膜移植术(PKP)和无缝线巩膜固定术(SSF)的手术效果,以解决玻璃体切除术后眼的角膜衰竭和无晶状体问题,并讨论这种新方法的最终优势。
两名患者在穿透性眼外伤后接受了一期伤口修复和平坦部玻璃体切除术,随后转诊至作者的诊所。在球后麻醉下进行PKP和SSF-卡尔维勒晶状体植入术。记录术中及术后并发症,使用眼前节光学相干断层扫描(AS-OCT)评估人工晶状体的位置,并使用内皮显微镜测定内皮细胞密度。两名患者均完成了12个月的随访。
手术过程中无术中并发症。1个月后,晶状体固定良好,移植片无排斥迹象。在12个月后的最后一次随访中,两例患者的角膜移植片均保持透明,内皮细胞密度良好;随访期间未发生结膜瘢痕形成或炎症以及封堵物外露。第一例患者的最佳矫正视力为4/10 Snellen,而在第二例患者中,由于视网膜问题,视力仅有限恢复至1/20 Snellen。
我们报告了使用卡尔维勒晶状体联合穿透性角膜移植术进行二期人工晶状体植入的可行性。通过经巩膜封堵物植入卡尔维勒晶状体相对容易,缩短了开放眼球的长度,使手术更安全,特别是对于玻璃体切除术后的眼睛。